Lenacapavir Use in France: A National, Observational Study (LENAddOn).

Ghosn J, Pourcher V, Allavena C, Hocqueloux L, Lacombe K, Cua E, Bonnet F, Duvivier C, Makinson A, Jacomet C, Lascoux C, Viard JP, Robineau O, Hentzien M, Teicher E, Pialoux G, Abgrall S, Cazanave C, Cabié A, Dudoit Y, Peytavin G, Barrière G, Dunn K, Marcelin AG, Assoumou L, Palich R, LENAddOn Study Group, LENAddOn Study Group

Open source

DOI: 10.1093/ofid/ofag512
Published: 2026 Aug
Container: Open forum infectious diseases
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/ofid/ofag512,
  title = {Lenacapavir Use in France: A National, Observational Study (LENAddOn).},
  author = {Ghosn J and Pourcher V and Allavena C and Hocqueloux L and Lacombe K and Cua E and Bonnet F and Duvivier C and Makinson A and Jacomet C and Lascoux C and Viard JP and Robineau O and Hentzien M and Teicher E and Pialoux G and Abgrall S and Cazanave C and Cabié A and Dudoit Y and Peytavin G and Barrière G and Dunn K and Marcelin AG and Assoumou L and Palich R and LENAddOn Study Group and LENAddOn Study Group},
  year = {2026},
  journal = {Open forum infectious diseases},
  doi = {10.1093/ofid/ofag512},
  url = {https://doi.org/10.1093/ofid/ofag512}
}

RIS

TY  - JOUR
TI  - Lenacapavir Use in France: A National, Observational Study (LENAddOn).
AU  - Ghosn J
AU  - Pourcher V
AU  - Allavena C
AU  - Hocqueloux L
AU  - Lacombe K
AU  - Cua E
AU  - Bonnet F
AU  - Duvivier C
AU  - Makinson A
AU  - Jacomet C
AU  - Lascoux C
AU  - Viard JP
AU  - Robineau O
AU  - Hentzien M
AU  - Teicher E
AU  - Pialoux G
AU  - Abgrall S
AU  - Cazanave C
AU  - Cabié A
AU  - Dudoit Y
AU  - Peytavin G
AU  - Barrière G
AU  - Dunn K
AU  - Marcelin AG
AU  - Assoumou L
AU  - Palich R
AU  - LENAddOn Study Group
AU  - LENAddOn Study Group
PY  - 2026
JO  - Open forum infectious diseases
DO  - 10.1093/ofid/ofag512
UR  - https://doi.org/10.1093/ofid/ofag512
ER  -

APA

J, G., V, P., C, A., L, H., K, L., E, C., F, B., C, D., A, M., C, J., C, L., JP, V., O, R., M, H., E, T., G, P., S, A., C, C., A, C., Y, D., G, P., G, B., K, D., AG, M., L, A., R, P., Group, L. S., & Group, L. S. (2026). Lenacapavir Use in France: A National, Observational Study (LENAddOn).. Open forum infectious diseases. https://doi.org/10.1093/ofid/ofag512

Source records

pubmed · retrieved 2026-09-26T10:53:12.492Z